NDC 51662-1487 – Glycopyrrolate
Glycopyrrolate .2 mg/mL · Injection · Intramuscular, Intravenous
Product NDC51662-1487
Product details
- Brand name
- Glycopyrrolate
- Generic name
- Glycopyrrolate
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA090963
- Marketed since
- January 11, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic; Cholinergic Muscarinic Antagonist
Active ingredients
- Glycopyrrolate .2 mg/mL
Uses, dosage, side effects and warnings for Glycopyrrolate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51662-1487-1 | 1 mL in 1 VIAL (51662-1487-1) | Jan 11, 2020 |
| 51662-1487-3 | 25 POUCH in 1 BOX (51662-1487-3) / 1 VIAL in 1 POUCH (51662-1487-2) / 1 mL in 1 VIAL | May 11, 2021 |
Recalls mentioning this NDC
- D-0870-2023 Jun 14, 2023 · Class III
Labeling: Label Mix-up
Other Glycopyrrolate products
- 16729-472 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-474 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-473 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 16729-471 Glycopyrrolate .2 mg/mL · Injection · Accord Healthcare, Inc.,
- 62332-607 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 62332-629 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 62332-628 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 62332-627 Glycopyrrolate .2 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 70121-1395 Glycopyrrolate .4 mg/2mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1397 Glycopyrrolate 4 mg/20mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1394 Glycopyrrolate .2 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1396 Glycopyrrolate 1 mg/5mL · Injection · Amneal Pharmaceuticals LLC